Pulmonary tuberculosis and venous thromboembolism

  • Authors

    • faouzia kambouche university of mostaganem
    • Labdouni Mohamed El Habib 1Department of Pulmonology, university hospital center of Mostaganem, faculty of medicine of Mostaganem -Algeria
  • Acute infections are among the risk factors for venous thromboembolism (VTE). The role of chronic infections such as active tuberculosis is poorly defined, although several case reports and case series have suggested a link association between tuberculosis and VTE. The unexpected resurgence of tuberculosis (TB) in developed countries provided the rationale for evaluating VTE as a possible complication of TB; never theless, the topic has received little attention in the literature.

    Patient and Method: This is a prospective multicenter study done between January 2016 and January 2018. It is about 17 cases of confirmed pulmonary tuberculosis associated with deep vein thrombosis.

    Results: It is about fifteen men and two women, their average age is 44,88 years. The thromboembolic complication revealed tuberculosis among 2patients, appearing during the hospitalization of 15 patients among which 11of them receiving antituberculosis drug. We have listed 3 cases of immediate pulmonary embolism and 14cases of deep vein thrombosis complicated with pulmonary embolism in 7 cases. These patients received anti-tuberculosis treatment according to the 2RHZE / 4RH protocol and a curative anticoagulant treatment based on low molecular weight heparin. A relay by vitamin K antagonists was instituted after a satisfactory INR control. The average time to effective anticoagulation was 15.12 days with extremes between 08 and 50 days.

    There was favorable evolution among 14 patients, 1of them was lost to follow-up. Sight and the evolution has been fatal in two case.

    Conclusion: Thromboembolic (DVT) disease must be sought systematically in the TB patients because of the risk of this complication particularly in extensive and severe forms. Prophylactic anticoagulation therapy finds its indications in these forms.

  • References

    1. Irene M., Mackman N., Kriett J. et al Prothrombotic activation of pulmonary arterial endothelial cells in patient with tuberculosis.Hum Pathol. 1996, 27:423-27. https://doi.org/10.1016/S0046-8177(96)90118-5.
    2. Fekih L., Oueslati I., Fenniche S. et al Association of deep vein thrombosis with pulmonary tuberculosis.Tunis Med. 2009, 87(5):328-9.
    3. Delluc A., Le Ven F., Mottier D. et al Epidemiology and risk factors of throm-boembolic venous disease Journal of Respiratory Dis-eases, 2012, 29: 254-266. https://doi.org/10.1016/j.rmr.2011.12.001.
    4. Fourrier F. Hemostasis disorders and serious infectious conditions. Med Infection Diseases, 2006, 36:524-33. https://doi.org/10.1016/j.medmal.2006.10.003.
    5. Sezer M, Ozturk A, Ilvan A et al The hemostatic changes in active pulmonary tuberculosis.Turkish Journal of Haematology, 2001, 18:95-100.
    6. Boukhris I., Bouslama K., Abdallah M. et al Deep vein thrombosis revealing tuberculosis. Rheumatology review,, 2006, 73:1118-9. https://doi.org/10.1016/j.rhum.2006.10.249.
    7. Schitrit D., Preiss R., Bargil-Shitrit et al Incidence of venous thromboembolism in 474 patients with acute tuberculosis Am J Respir Crit Care Med, 2004, 169: 135-138.
    8. Toure N.O., Kane Y.D., Diatta A. et al Tuberculosis and thrombophlebitis of the lower limbs Journal of Respiratory Diseases 2007, 24: 126. https://doi.org/10.1016/S0761-8425(07)72789-4.
    9. Fall K.B, Camara P., Sane M. et al Tuberculosis and thromboembolic disease: a dangerous link not always apparent Trop Med, 2004, 64 : 271-274.
    10. Gogna A., Pradhan GR., Sinha RSH. et al Tuberculosis presenting as deep vein thrombosis Postgrad Med J, 1999, 75: 104-106. https://doi.org/10.1136/pgmj.75.880.104.
    11. Naithani R., Agrawa N., Choudhary VP et al Deep venous thrombosis associated with tuberculosis Blood Coagul Fibrinolysis, 2007, 18: 377-380. https://doi.org/10.1097/MBC.0b013e3280d942b4.
    12. Mark PL, Ashok PP, Deshpande RB et al A patient with hypercoagulable state due to tuberculosis. Indian J Chest Dis Allied Sci, 2009, 51(1):49-51. This article on PubMed.
    13. Nou M. Rodiere M. Schved J.F. et al Infections and venous thrombosis in pediatrics: analysis of a series of 24 cases Pediatric Archives, 2014, 21:697-704. https://doi.org/10.1016/j.arcped.2014.04.031.
    14. Turken O., Kunter E., Sezrz M., et al Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis, 2002, 6(10):927-32. This article on PubMed
    15. Bourguignon L., Golfier L., Chatillon F. et al. Interaction between acenocoumarol and rifampicin: case report and pharmacokinetic mechanisms involved, Journal of Clinical Pharmacy 2006, 25(2): 105-109.
    16. Aissa I., Rachdi I., Ben Miled K. et al. Incidence of venous thromboembolic disease in men admitted to a pulmonology department for acute respiratory disease. Journal of Clinical Pneumology, 2011, 67: 129-135. https://doi.org/10.1016/j.pneumo.2010.04.003.
    17. Smeeth L, Cook C, Thomas S. et al Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet, 2006, 367:1075-9. https://doi.org/10.1016/S0140-6736(06)68474-2.
  • Downloads

  • How to Cite

    kambouche, faouzia, & Mohamed El Habib , L. (2024). Pulmonary tuberculosis and venous thromboembolism. International Journal of Medicine, 12(1), 1-3. https://doi.org/10.14419/3aymyf47